Published August 28, 2025 | Version v1

Oliceridine: Progress in Clinical Research on a New Analgesic Drug

Authors/Creators

  • 1. The Research Units of West China (2018RU012), Chinese Academy of Medical Sciences, Chengdu, Sichuan Province, China
  • 2. Department of Anesthesiology, West China Hospital, Sichuan University, Chengdu, Sichuan Province, China

Description

Oliceridine is a new class of μ-opioid receptor agonists, which is relatively selective to μ-opioid receptors and exerts analgesic effects by interacting with μ-opioid receptors (MORS). Compared with morphine, it has the characteristics of fast onset, strong analgesic effect, low incidence of respiratory depression and gastrointestinal adverse reactions, and less neurological complications. It is a safe and effective intravenous analgesic, providing a better choice for the treatment of patients with moderate to severe acute pain. In this paper, the mechanism of action, pharmacodynamics and pharmacokinetics, clinical application and development trend of oliceridine were reviewed, so as to provide theoretical basis for clinical application.

Files

Oliceridine - Progress in Clinical Research on a New Analgesic Drug.pdf

Files (384.2 kB)

Additional details

Identifiers

DOI
10.36502/2025/ASJBCCR.6422
ISSN
2582-0370

Dates

Accepted
2025-08-21